569 related articles for article (PubMed ID: 26183258)
1. Primary and Secondary Thrombotic Microangiopathy Referred to a Single Plasma Exchange Center for Suspected Thrombotic Thrombocytopenic Purpura: 2000-2011.
Dahlan R; Sontrop JM; Li L; Ghadieh O; Clark WF
Am J Nephrol; 2015; 41(6):429-37. PubMed ID: 26183258
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center.
Kim JW; Kim I; Oh KH; Yoon SS; Oh MD; Song YW; Heo DS; Bang YJ; Han KS; Han JS; Park S; Kim BK
Hematology; 2011 Mar; 16(2):73-9. PubMed ID: 21418736
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
Clark WF
Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
[TBL] [Abstract][Full Text] [Related]
4. Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Bittencourt CE; Ha JP; Maitta RW
PLoS One; 2015; 10(5):e0127744. PubMed ID: 26000799
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Hayward CP; Sutton DM; Carter WH; Campbell ED; Scott JG; Francombe WH; Shumak KH; Baker MA
Arch Intern Med; 1994 May; 154(9):982-7. PubMed ID: 8179455
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O
Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
[TBL] [Abstract][Full Text] [Related]
7. Treating TTP/HUS with plasma exchange: a single centre's 25-year experience.
Forzley BR; Sontrop JM; Macnab JJ; Chen S; Clark WF
Br J Haematol; 2008 Oct; 143(1):100-6. PubMed ID: 18691172
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients.
Levandovsky M; Harvey D; Lara P; Wun T
J Hematol Oncol; 2008 Dec; 1():23. PubMed ID: 19046460
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Elliott MA; Nichols WL
Mayo Clin Proc; 2001 Nov; 76(11):1154-62. PubMed ID: 11702904
[TBL] [Abstract][Full Text] [Related]
10. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.
Coppo P; Bussel A; Charrier S; Adrie C; Galicier L; Boulanger E; Veyradier A; Leblanc T; Alberti C; Azoulay E; Le Gall JR; Schlemmer B
Medicine (Baltimore); 2003 Jan; 82(1):27-38. PubMed ID: 12544708
[TBL] [Abstract][Full Text] [Related]
11. Predictors of response and relapse in a cohort of adults with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a single-institution experience.
Tuncer HH; Oster RA; Huang ST; Marques MB
Transfusion; 2007 Jan; 47(1):107-14. PubMed ID: 17207238
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases.
Dervenoulas J; Tsirigotis P; Bollas G; Pappa V; Xiros N; Economopoulos T; Pappa M; Mellou S; Kostourou A; Papageorgiou E; Raptis SA
Ann Hematol; 2000 Feb; 79(2):66-72. PubMed ID: 10741917
[TBL] [Abstract][Full Text] [Related]
13. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.
Bell WR; Braine HG; Ness PM; Kickler TS
N Engl J Med; 1991 Aug; 325(6):398-403. PubMed ID: 2062331
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in children and adolescents.
Lowe EJ; Werner EJ
Semin Thromb Hemost; 2005 Dec; 31(6):717-30. PubMed ID: 16388423
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis on thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, with plasma level of cytokine].
Wada H; Saitoh M; Tamaki S; Masuya M; Morita K; Tabata M; Tanigawa M; Kageyama S; Tsuzi K; Ohta C
Rinsho Ketsueki; 1990 Sep; 31(9):1537-43. PubMed ID: 2246829
[TBL] [Abstract][Full Text] [Related]
16. The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: evaluation, management, and long-term outcomes experience of the Oklahoma TTP-HUS Registry, 1989-2007.
George JN
Kidney Int Suppl; 2009 Feb; (112):S52-4. PubMed ID: 19180137
[TBL] [Abstract][Full Text] [Related]
17. Frequency and significance of schistocytes in TTP/HUS patients at the discontinuation of plasma exchange therapy.
Egan JA; Hay SN; Brecher ME
J Clin Apher; 2004; 19(4):165-7. PubMed ID: 15597353
[TBL] [Abstract][Full Text] [Related]
18. [Thrombotic microangiopathy in adults].
Barrientos GJ; Michelangelo H
Medicina (B Aires); 2006; 66(4):289-95. PubMed ID: 16977962
[TBL] [Abstract][Full Text] [Related]
19. TTP/HUS and prognosis: the syndrome and the disease(s).
Forzley BR; Clark WF
Kidney Int Suppl; 2009 Feb; (112):S59-61. PubMed ID: 19180139
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology and management of thrombotic microangiopathies.
Ruggenenti P; Remuzzi G
J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
